Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2004 048 082.7 |
| 96 | EP file number | EAKZ | 11 18 5507.8 |
| 97 | EP publication number | EPN | 2441449 |
| 54 | Designation/title | TI | Modulation der Apolipoprotein-C-III-Expression |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/00 (2006.01) |
| 22 | DE application date | DAT | Apr 15, 2004 |
| 96 | EP application date | EAT | Apr 15, 2004 |
| 43 | Date of first publication | OT | Apr 18, 2012 |
| Date of publication of grant | PET | Oct 14, 2015 |
| 71/73 | Applicant/owner | INH | Isis Pharmaceuticals, Inc., Carlsfeld, Calif., US |
| 72 | Inventor | IN | Crooke, Rosanne M., Carlsbad, CA 92009, US; Graham, Mark J., San Clemente, CA 92672, US; Lemonidis Tarbet, Kristina M., Oceanside, CA 92057, US; Dobie, Kenneth, Del Mar, CA 92014, US |
| 74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
418780
Apr 16, 2003
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002441449
Searchable text:
EP000002441449
Original document:
EP000002441449B1
Searchable text:
EP000002441449B1 |
| 43 | Date of first publication | EVT | Apr 18, 2012 |
| Date of the first transfer into DPMAregister | EREGT | Jun 1, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 17, 2024
(Show all update days)(Hide all update days)- Jun 1, 2012
- Date of the first transfer into DPMAregister
|
